You are here
Plants
Hydrastis canadensis
EOL Text
Goldenseal (Hydrastis canadensis L. ) is a North American woodland herb with a yellow perennial rhizome. A new stem grows each year about 30 cm high. The leaves are large (up to 30 cm wide), usually with five lobes. A single white flower, a mass of stamens with no petals, is produced from late April to May, depending on latitude and altitude, followed in July by a bright red berry with 10 to 30 black seeds. The natural range of the plant extends from southern New England west through the extreme southwestern portion of southern Ontario, to southern Wisconsin, and south to Arkansas and northern Georgia.
Goldenseal is highly valued for its rhizome and roots that contain medicinal alkaloids (Small and Catling, 1999). The roots have antibiotic properties, suppressing certain bacteria, protozoans, and fungi, and are used to treat AIDS and other severe chronic diseases, and digestive disorders, and to enhance the immune system (Davis and Bit, 1998). Commercial formulations prepared from the plant are widely used to treat colds and nasal congestion, as well as certain infections and parasites (Small and Calling, 1999).
Rounded Global Status Rank: G3 - Vulnerable
Reasons: Goldenseal, Hydrastis canadensis, an herbaceous understory species of the eastern deciduous forest, with the core of its range in Indiana, Kentucky, Ohio and West Virginia (Sinclair and Catling 2000a). It extends north into Ontario, Canada and as far south in the United States to Alabama, east to North Carolina and north to Vermont.
Goldenseal may be best known for its use as an herbal supplement for a variety of health purposes, including as an immune booster and anti-inflammatory agent. Its earliest known use was by indigenous people in the eastern North America and by the 1700s it was used as a digestion aid and treatment for skin imflammation (Barton 1798). Its use is well documented from the 1800s to the present, with increasing demand through time as markets expanded beyond local usage. The species has been primarily wild-harvested, and over-collection of the plant is a predominate threat.
Concern due to over-collection is expressed at the national levels both in the United States and Canada. Since 1997, goldenseal has been listed in Appendix II of the Convention for International Trade on Endangered Species of Wild Fauna and Flora (CITES), with an annotation to regulate the underground parts (i.e. roots, rhizomes): whole, parts and powdered. A CITES Appendix-II listing requires that exporters obtain permits or certificates to ensure that international trade is legal and is not detrimental to the survival of the species in the wild. In Canada, goldenseal is designated 'threatened' by the Committee on the Status of Endangered Wildlife in Canada (COSEWIC).
Long-term decline since the beginning of its harvest history is evident, and short term trends are more localized, from declining to stable. State conservation statuses range from vulnerable to critically imperiled in the periphery of the range, to uncommon and secure in the core of its range. As of 2013, the species is state-listed as endangered, vulnerable or threatened in at least ten states. Seven of the states within goldenseal's range do not have State plant endangered species lists or protection laws.
Goldenseal, from a rangewide perspective and in a classical perspective of distribution and abundance is currently uncommon to secure, however, from a more holistic conservation perspective the extent of threats, long-term trends and short-term trends demand continuous and close monitoring in both the United States and Canada.
Environmental Specificity: Moderate. Generalist or community with some key requirements scarce.
Previously available only in specialty health and natural foods stores, goldenseal and other medicinal herbs became part of the general marketplace during the 1990s, and since then the demand has been increasing dramatically (Foster, 2000). Between 1991 and 1996, the wholesale value of goldenseal in the U.S. increased by as much as 600% (Robbins, 1996). Since 1994 goldenseal has been one of the top six best selling medicinal herbs in the U.S. (Robbins, 1996; Small and Catling, 1999), and remains so today (Foster, 2000). Between 1995 and 1997, the medicinal plant market as a whole, as well as demand for goldenseal, experienced in excess of a 30% growth rate (USFWS, 1997). Goldenseal is also available in numerous drug products (Small and Catling, 1999) and in a wide array of herbal products on international markets, e.g., in France, Australia, Germany, United Kingdom, Italy, and other European countries (IUCN, 1997; Robbins, 1996). Since demand has increased greatly, and supplies have declined, the price of goldenseal has increased dramatically. In the early 1990s, the price of goldenseal ranged from $18 to $24 per kg (Foster, 2000). In 1999, the price ranged from $66 to $110 per kg (Davis, 1999c; Foster, 2000). In 2000, the price of goldenseal was over $110 per kg, with some companies charging over $220 per kg (Foster, 2000; Price lists on World Wide Web). The current goldenseal shortage and the large increase in its demand appear to highlight the need for cultivated supplies to satisfy a growing domestic and international market (Foster, 2000).
orangeroo, yellow-puccoon, fard inolien, hydrastis du Canada, racirie jaunisse, sceau d'or, kanadische Orangewurz, hidrastis, raíz de oro
Stewardship Overview: Populations should be monitored for impacts related to harvest, and wild-collection is a primary threat to this species. Most populations of goldenseal are made-up of 1000 and fewer stems, and while populations may be small protecting even the smallest should be considered. Goldenseal maintains a mixed-breeding system and is able to self-pollinate to produce fruit, as well as produce sterile stems (non-flowering) that are genetically identical to other stems in the same patch (Christensen and Gorchov 2010, Sanders 2004). Since goldenseal is capable of self-pollination to set fruit, even small populations can be long-lived, and can act as sources of genetic variability for other nearby populations (Sanders 2004). Further, populations in small areas should be considered for conservation based on research that showed that goldenseal responds favorably to light and soil disturbance, and larger populations were associated with small habitat area (Sinclair and Catling 200b). A genetic study in North Carolina showed that while higher levels of genetic diversity were measured within populations, that genetic and allelic diversity was low across populations suggesting that reintroductions into populations would not likely cause outbreeding depression (Torgerson 2012).
Studies show that the best measure of past collection is the number of fertile (Sinclair and Catling 2000, Christensen and Gorchov 2010) and large sterile plants (Christensen and Gorchov 2010) from year to year, as these two life classes are responsible for maintaining or proliferating population size.
Data collection on environmental conditions such as temperature, precipitation and soil nutrients should be maintained over the life of any monitoring program. Buds for next year's stems are formed in summer or fall (Sinclair and Catling 2000) and spring growth is likely linked with the size of the flower bud and a determiner of whether plants will reproduce vegetatively or sexually in a given year (Christensen and Gorchov 2010). Growth is dependent on precipitation and temperature, and in one study high levels of soil nutrients (especially phosphorus) promoted growth of young stems (Sinclair and Catling 2000).
Other data related to the habitat should also be collected, such as percent canopy cover and soil displacement by animals and uprooted trees since goldenseal positively responds to mild disturbance, particularly light gaps and some soil disturbance (McGraw et al. 2003). Management and monitoring of patches should be done based on changes in leaf-area from year to year, and not stem count. Results from illicitly harvested patches in West Virginia show that leaf-area was immediately and negatively affected compared to pre-harvest leaf-area, and that stem-counts do not clearly relate to pre-harvest numbers (Sanders and McGraw 2005). Finally, if populations are harvested, the time of year this takes place should be noted. Albrecht and McCarthy (2006) found that fall-harvested populations may recover faster than those harvested in the mid-summer.
Success in monitoring and managing population dynamics is dependent on the knowledge of the data collectors and program managers, since understanding the reproductive life history of this plant is critical (i.e. it is known that large sterile (non-flowerig) plants transition back and forth from fertile plants) for accurate tracking of population health and viability. Further, managers should know the local phenology pattern of the plant from emergence to senescence. Detailed information about the life history of goldenseal is available in Christensen and Gorchov (2010), general biology and complexities associated with management are provided in Sinclair and Catling (2000), and diagram of the root (used in medicinal compounds) available in Van der Voort et al. (2003).
The native Goldenseal occurs occasionally in scattered counties throughout Illinois (see Distribution Map), although populations have been declining because of habitat destruction and over-collection of the rhizomes. Habitats include moist to mesic deciduous woodlands, wooded bluffs, and areas along woodland paths. A limited amount of disturbance is beneficial when it reduces excessive shade from the overhead canopy. Faunal Associations
License | http://creativecommons.org/licenses/by-nc/3.0/ |
Rights holder/Author | Copyright © 2002-2014 by Dr. John Hilty |
Source | http://www.illinoiswildflowers.info/woodland/plants/goldenseal.htm |
Please consult the PLANTS Web site and your State Department of Natural Resources for this plant’s current status (e.g. threatened or endangered species, state noxious status, and wetland indicator values).
The following topics are addressed in the publication, Cultivating the increasingly popular medicinal plant, goldenseal: Review and update by Adrianne Sinclair and Paul M. Catling, which is reproduced below.
This publication was reproduced from the American Journal of Alternative Agriculture, volume 16 (3), with permission from the authors and the American Journal of Alternative Agriculture.
Cultivating the increasingly popular medicinal plant, goldenseal: Review and update
Adrianne Sinclair and Paul M. Catling
Abstract. Interest in the cultivation of goldenseal is increasing and this may have benefits for agriculture, human health, and conservation. To enable a better understanding of growing conditions, cultivation methods reported in the literature were reviewed, 21 natural goldenseal populations in the northern portion of its natural range in North America were described and analyzed in terms of population size and health, and 15 successful growers were interviewed on requirements for optimal cultivation. Growing conditions in the wild were compared to those reported in the cultivation literature. Summary of data from natural populations suggests goldenseal grows best in mixed hardwood forests, under 60 65% shade, in moist sandy loam soils high in organic matter, with pH 5.7 to 6.3. Similarly, review of the literature suggests that goldenseal grows best in moist, well drained loams high in organic matter, with pH 5.5 to 6.5. Reported shade requirements vary but 47 80% shade is considered optimal. Growing conditions reported by growers were also consistent with the cultivation literature and similar to conditions of wild populations. Although optimal growing conditions are similar to those for many crops, goldenseal is relatively robust and can grow well in a variety of conditions including wet, predominantly sandy or clay soils with pH as low as 4.8 and as high as 7.8. Cultivation can utilize a ginseng crop infrastructure and goldenseal has been recommended as a rotation crop for ginseng. Commercial production of goldenseal is potentially advantageous because (1) it is an environmentally friendly crop; (2) it has been grown successfully far outside its natural range, is easy to grow, and is considered potentially profitable; and (3) it is relatively inexpensive, having low energy, land area, and fertilization requirements. Development of a sustainable crop may contribute to the protection of native wild gennplasm, which can provide valuable material for crop improvement.
Goldenseal (Hydrastis canadensis), also called orangeroot[3] or yellow puccoon,[3] is a perennial herb in the buttercup family Ranunculaceae, native to southeastern Canada and the eastern United States. It may be distinguished by its thick, yellow knotted rootstock. The stem is purplish and hairy above ground and yellow below ground where it connects to the yellow rhizome. The plant bears two palmate, hairy leaves with 5–7 double-toothed lobes and single, small, inconspicuous flowers with greenish white stamens in the late spring. It bears a single berry like a large raspberry with 10–30 seeds in the summer.[4]
Goldenseal has been ascribed[according to whom?] the following herbal properties (whole herb): bitter, hepatic, alterative, anticatarrhal, anti-inflammatory, antimicrobial, laxative, emmenagogue, and oxytocic.[5]
Goldenseal is often used as a multi-purpose remedy, and is thought[according to whom?] to possess many different medicinal properties. In addition to being used as a topical antimicrobial, it is also taken internally as a digestion aid.[citation needed] Goldenseal may be purchased in salve, tablet, tincture form, or as a bulk powder. Goldenseal is often used to boost the medicinal effects of other herbs with which it is blended or formulated.
A second species from Japan, previously listed as Hydrastis palmatum, is sufficiently distinct that it is now usually treated in a separate genus, as Glaucidium palmatum.
Contents
Efficacy[edit]
There is currently insufficient evidence to determine whether goldenseal is effective for any conditions.[6][7][8] According to the American Cancer Society, "evidence does not support claims that goldenseal is effective in treating cancer or other diseases. Goldenseal can have toxic side effects, and high doses can cause death."[9]
Traditional usage[edit]
At the time of the European colonization of the Americas, goldenseal was in extensive use among certain Native American tribes of North America, both as a medicine and as a coloring material. Prof. Benjamin Smith Barton in his first edition of Collections for an Essay Toward a Materia Medica of the United States (1798), refers to the Cherokee use of goldenseal as a cancer treatment. Later, he calls attention to its properties as a bitter tonic, and as a local wash for ophthalmia. It became a favorite of the Eclectics from the time of Constantine Raffinesque in the 1830s.
Herbalists today consider goldenseal an alterative, anti-catarrhal, anti-inflammatory, antiseptic, astringent, bitter tonic, laxative, anti-diabetic and muscular stimulant. They discuss the astringent effect it has[citation needed] on mucous membranes of the upper respiratory tract, the gastrointestinal tract, the bladder, and rectum (applied topically), and the skin. Goldenseal is very bitter, which stimulates the appetite and aids digestion, and often stimulates bile secretion.[10][11][unreliable source?][12][13]
Mechanism of action[edit]
Herbalist Paul Bergner investigated the research and has been unable to find case reports where the level of intestinal pathogens are lower after taking goldenseal.[14] In fact, a study by Rabbani[15] where men with E. coli induced diarrhea had 42–48% reduced symptoms after taking berberine showed unchanged levels of intestinal bacteria, pathogenic or otherwise.
It appears likely that goldenseal shares with Mahonia (Oregon grape) and Berberis (Barberry) the ability to inhibit the drug resistance efflux pumps (MDR pumps) of bacteria, as discussed below.
Constituents and modern pharmacology[edit]
Goldenseal contains the isoquinoline alkaloids: hydrastine, berberine, berberastine, hydrastinine, tetrahydroberberastine, canadine, and canalidine.[16] A related compound, 8-oxotetrahydrothalifendine was identified in one study.[17] One study analyzed the hydrastine and berberine contents of twenty commercial goldenseal and goldenseal-containing products and found they contained variously 0%-2.93% hydrastine and 0.82%-5.86% berberine.[18] Berberine and hydrastine act as quaternary bases and are poorly soluble in water but freely soluble in alcohol. The herb seems to have synergistic antibacterial activity over berberine in vitro, possibly due to efflux pump inhibitory activity.[19]
Multiple bacteria and fungi, along with selected protozoa and chlamydia are susceptible to berberine in vitro.[20] Berberine alone has weak antibiotic activity in vitro since many microorganisms actively export it from the cell (although a whole herb is likely to work on the immune system as well as on attacking the microbes and hence have a stronger clinical effect than the antibiotic activity alone would suggest).[citation needed] Interestingly, there is some evidence for other berberine-containing species synthesizing an efflux pump inhibitor that tends to prevent antibiotic resistance, a case of solid scientific evidence that the herb is superior to the isolated active principle.[21] However, it is not yet known whether goldenseal contains a drug resistance efflux pump inhibitor, although many antimicrobial herbs do.[citation needed]
Toxicity[edit]
Most of the research that is popularly attributed to goldenseal has actually been into the constituent berberine, which goldenseal has in common with a variety of other medicines including oregon-grape, Coptis, Phellodendron, barberry (Berberis vulgaris) and yellowroot (Xanthorhiza simplicissima). However, constituents frequently act differently in isolation than a whole herb acts in the body. In 1996, the committee of the European Union that regulates drugs placed barberry in a table of Herbal Drugs with Serious Risks without any Accepted Benefit because it contains berberine.[citation needed] Paul Bergner investigated the literature and was able to find only a single report of potential adverse effects of berberis species, berberine-containing plants, or berberine itself in a computer search of the MEDLINE and TOXLINE databases of the U.S. National Library of Medicine. This was a study in China that showed that berberine sulfate is inappropriate for the treatment of newborn infants with prenatal jaundice.[22] However that is not a likely scenario in a country where babies born jaundiced are hospitalized, but it does lend credence to the traditional advice not to take goldenseal or other berberine herbs during pregnancy.[23]
Research into the toxicology and pharmacology of goldenseal has focused on berberine and hydrastine, which are antimicrobial, chloretic and each have a variety of other properties helping immunity. But toxicity in a concentrated constituent does not translate to toxicity of the whole herb, which contains many other compounds. In one study, the lethal dose (LD50) for rats was 12 times lower with hydrastine than with goldenseal extract.[24][25]
A study where pregnant rats were fed about 47 times the usual human dose of 26 mg/kg concluded, "Maternal liver weights were increased at ≥6250 ppm, suggesting possible enzyme induction. There was no definitive evidence of developmental toxicity in this study."[26] Another study, where mice were fed ~300 times the estimated human intake from dietary supplements, concluded, "Maternal liver weights were increased at greater than 12,500 ppm, but in the absence of treatment-related histopathological lesions. At the high dose, definitive evidence of developmental toxicity was limited to a statistically significant (~8%) reduction in average fetal body weight per litter."[27]
The lethal dose (LD50) of berberine isolates in humans is thought to be 27.5 mg/kg. Berberine is absorbed slowly orally; it achieves peak concentrations in 4 hours and takes 8 hours to clear[28] Berberine is excreted in the urine and human studies of berberine show evidence it can be absorbed through the skin. Pharmacokinetic data is not available for hydrastine or goldenseal root powder. Berberine in humans can cause blocking of receptors in smooth muscle, blocking potassium channels in the heart and reducing ventricular tachycardia, inhibiting intestinal ion secretion and toxin formation in the gut and increasing bile secretion.[29]
While goldenseal, like all alkaloid-rich herbs including coffee and tobacco should be avoided during pregnancy and given to very young children with care, it appears that goldenseal is unlikely to be toxic in normal doses. Interactions with drugs with narrow therapeutic windows like warfarin, ciclosporin, protease inhibitors and cardiac glycosides are potential concerns.
Side effects of goldenseal may include "digestive complaints, nervousness, depression, constipation, rapid heartbeat, diarrhea, stomach cramps and pain, mouth ulcers, nausea, seizures, vomiting, and central nervous system depression. High doses may cause breathing problems, paralysis, and even death. Long-term use may lead to vitamin B deficiency, hallucinations, and delirium."[9] In addition, goldenseal may cause brain damage to newborn babies if given to them directly or if taken by their breastfeeding or pregnant mothers,[6] and may affect blood pressure unpredictably because it contains several different compounds that have opposite effects on blood pressure.[9]
Cautions[edit]
Goldenseal has an affinity for mucosa, and is cooling so should not be used if an infection is at an early stage or there are more chills than fever.[citation needed] Goldenseal should be used with caution only while sick with illnesses that respond to hydrastine and berberine. It should generally not be taken for an early stage Upper Respiratory Infection (URI), but reserved for illnesses in which there is yellow or green phlegm.[citation needed] Generally a two-week maximum dosage is suggested.[citation needed] Taking goldenseal over a long period of time can reduce absorption of B vitamins. Avoid goldenseal during pregnancy and lactation, with gastrointestinal inflammation, and with proinflammatory disorders.[13] A recent study (2011) found rats fed with Goldenseal constantly for two years had a greater tendency towards tumor formation.[30]
Goldenseal has been found to have inhibited cytochrome P450 CYP2D6, CYP3A4, and CYP3A5 activity by approximately 40%, a statistically and clinically significant reduction.[31] CYP2D6 specifically is a known metabolizer of many commonly used pharmaceuticals, such as antidepressants (including all SSRIs except for fluvoxamine), neuroleptics, and codeine.[32] Combining Goldenseal with such medications should be done with caution and under the supervision of a doctor as it can lead to serious - perhaps fatal - toxicity.[33] Those with a genetic deficiency in these enzymes are at particular risk.
Use for masking illicit drug use in urine drug tests[edit]
Goldenseal became a part of American folklore associated with chemical testing errors, from pharmacist John Uri Lloyd's 1900 novel Stringtown on the Pike. In the book, the victim's habit of taking goldenseal in the form of digestive bitters, causes this herb to appear as the poison strychnine in a chemical test - thus suggesting murder. It has been used on occasions in this century to attempt to mask the use of morphine in race horses (without success).[34]
Two studies have demonstrated no effect of oral goldenseal on urine drug assays over water alone.[35] Subjects who drank large amounts of water had the same urine drug levels as subjects who took goldenseal capsules along with the water.
Endangered status[edit]
Goldenseal became popular in the mid-nineteenth century. By 1905, the herb was much less plentiful, partially due to overharvesting and partially to habitat destruction. Wild goldenseal is listed in Appendix II of the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES),[36] which by definition means harvest from public land is prohibited and may require a permit to export, although trade of the plants is still deemed to be undetrimental to the wildlife population and is otherwise unregulated. More than 60 million goldenseal plants are picked each year without being replaced.[37] The process of mountain top removal mining has recently put the wild goldenseal population at major risk due to loss of habitat, illegality of removing goldenseal for transplant without registration while destruction in the process of removing the mountain top is permitted, and increased economic pressure on stands outside of the removal area.[38]
Many herbalists urge caution in choosing products containing goldenseal, as they may have been harvested in an unsustainable manner as opposed to having been organically cultivated.[citation needed]
There are several berberine-containing plants that can serve as useful alternatives, including Chinese coptis, yellowroot, or Oregon grape root.[39]
See also[edit]
References[edit]
- ^ Franz Eugen Köhler, Köhler's Medizinal-Pflanzen (1897)
- ^ "Hydrastis canadensis". NatureServe Explorer. NatureServe. Retrieved 2007-03-20.
- ^ a b "USDA GRIN Taxonomy".
- ^ Foster S. and Duke J. (2000): A Field guide to Medicinal Plants and Herbs of Eastern and Central North America. New York, Houghton Mifflin
- ^ Hoffman David (2003): Medical Herbalism. Rochester, Vermont, Healing Arts Press
- ^ a b Goldenseal, WebMD.
- ^ Goldenseal, NCCAM.
- ^ Goldenseal, NYU Langone Medical Center.
- ^ a b c Goldenseal, American Cancer Society.
- ^ Tierra Michael (1998): The Way of Herbs. New York, Pocket Books
- ^ Grieve M. (1971): A Modern Herbal. New York, Dover Publications, Inc
- ^ Mills S. and Bone K. (2000): Principles and Practice of Phytotherapy. Philadelphia, Churchill Livingstone
- ^ a b http://www.med.unc.edu/phyrehab/ncmedicinalherbs/goldenseal/Goldenseal-hp.pdf
- ^ [1] Bergner, Paul Goldenseal and the Antibiotic Myth Medical Herbalism: A Journal for the Clinical Practitioner Volume 8, Number 4, Winter 1996–1997
- ^ Rabbani GH, Butler T, Knight J, Sanyal SC, Alam K (May 1987). "Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae". The Journal of Infectious Diseases 155 (5): 979–84. doi:10.1093/infdis/155.5.979. PMID 3549923.
- ^ Weber HA, Zart MK, Hodges AE et al. (December 2003). "Chemical comparison of goldenseal (Hydrastis canadensis L.) root powder from three commercial suppliers". Journal of Agricultural and Food Chemistry 51 (25): 7352–8. doi:10.1021/jf034339r. PMID 14640583. CS1 maint: Explicit use of et al. (link)
- ^ Gentry EJ, Jampani HB, Keshavarz-Shokri A et al. (October 1998). "Antitubercular natural products: berberine from the roots of commercial Hydrastis canadensis powder. Isolation of inactive 8-oxotetrahydrothalifendine, canadine, beta-hydrastine, and two new quinic acid esters, hycandinic acid esters-1 and -2". Journal of Natural Products 61 (10): 1187–93. doi:10.1021/np9701889. PMID 9784149. CS1 maint: Explicit use of et al. (link)
- ^ Edwards DJ, Draper EJ, Variations in alkaloid content of herbal products containing goldenseal, J Am Pharm Assoc (2003). 2003 May-Jun;43(3):419-23.
- ^ Ettefagh K.A., Burns J.T., Junio H.A., Kaatz G.W., Cech N.B., "Goldenseal (Hydrastis canadensis L.) Extracts Synergistically Enhance the Antibacterial Activity of Berberine via Efflux Pump Inhibition", Planta Medica 2010
- ^ Mills, Simon; Bone, Kerry (2000). Principles and practice of phytotherapy: modern herbal medicine. Edinburgh: Churchill Livingstone. ISBN 978-0-443-06016-8. [page needed]
- ^ Lewis K (April 2001). "In search of natural substrates and inhibitors of MDR pumps". Journal of Molecular Microbiology and Biotechnology 3 (2): 247–54. PMID 11321580.
- ^ Chan E (1993). "Displacement of bilirubin from albumin by berberine". Biology of the Neonate 63 (4): 201–8. doi:10.1159/000243932. PMID 8513024.
- ^ [2] Bergner, Paul Goldenseal Substitutes Medical Herbalism: A Journal for the Clinical Practitioner Volume 8, Number 4, Winter 1996–1997
- ^ Tice Raymond (1997): Goldenseal and two of its constituent alkaloids: berberine and hydrastine Research Triangle Park, National Institute of Environmental Health Sciences, in Seiger E: Review of Toxilogical Literature.
- ^ Mills Simon and Bone Kerry (2000): Principles and Practice of Phytotherapy. Philadelphia, Churchill Livingstone.
- ^ (2003): Developmental Toxicity Evaluation for Goldenseal Root Powder (Hydrastis Canadensis) Administered in the Feed to Sprague-Dawley (CD) Rats on Gestational Days 6 to 20 Research Triangle Park, NC: National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health
- ^ Developmental Toxicity Evaluation for Goldenseal (Hydrastis canadensis) Root Powder Administered in the Feed to Swiss (CD-1) Mice on Gestational Days 6-17
- ^ Jellin J.M., Gregory P.J., Batz F. and Hitchens K. (2004): Pharmacist's Letter/ Prescriber's Letter Natural Medicines Comprehensive Database. Stockton, CA, Therapeutic Research Faculty. Accessed: 1/12/2004, http://www.naturaldatabase.com/member_home.asp?ph_img=memberhome.gif&ex=0&ex=0
- ^ Mills Simon and Bone Kerry (2000): Principles and Practice of Phytotherapy. Philadelphia, Churchill Livingstone.
- ^ Dunnick JK, "Investigating the Potential for Toxicity from Long-Term Use of the Herbal Products, Goldenseal and Milk Thistle." Toxicol Pathol. 2011 Feb 7;
- ^ http://www.ncbi.nlm.nih.gov/pubmed/15900287?dopt=Abstract
- ^ http://www.fass.se/LIF/produktfakta/fakta_lakare_artikel.jsp?articleID=18352
- ^ http://www.mendeley.com/research/fatal-intoxication-cases-cytochrome-p450-2d6-and-2c19-genotype-distributions/
- ^ Black Cohosh, Cimicifuga racemosa, Actaea racemosa, article and photos by Steven Foster
- ^ Jellin J.M., Gregory P.J., Batz F. and Hitchens K. (2004): Pharmacist's Letter/ Prescriber's Letter Natural Medicines Comprehensive Database. Stockton, CA, Therapeutic Research Faculty. http://www.naturaldatabase.com/member_home.asp?ph_img=memberhome.gif&ex=0&ex=0
- ^ Foster Steven and Tyler Varro E. (1999): Tyler's Honest Herbal: A sensible guide to the use of herbs and related remedies. Binghamton, NY, The Haworth Herbal Press
- ^ Dworkin, Norine (1999). "Where Have All the Flowers Gone? - herbal supplements threaten some herb species". Vegetarian Times.
- ^ http://cms.herbalgram.org/herbalgram/issue73/article3080.html?ts=1390375664&signature=31b6c6d2eaf40423702e4e49661ce6db Dean Myles Saving Wild Ginseng, Goldenseal, and other Native Plants from Mountain Top Removal. HerbalGram. 2007;73:50 © American Botanical Council
- ^ Bergner, Paul. The Healing Powers of Echinacea, Goldenseal and Other Immune System Herbs. Prima 1997 ISBN 978-0-7615-0809-0
Literature[edit]
- Blanchan, Neltje (2005). Wild Flowers Worth Knowing. Project Gutenberg Literary Archive Foundation. ISBN 0-665-98934-2.
- John Uri Lloyd (1908). Hydrastis canadensis. Lloyd Library, Cincinnati. PDF
- Bergner, Paul.(1997) The Healing Powers of Echinacea, Goldenseal and Other Immune System Herbs. Prima ISBN 978-0-7615-0809-0
- W. Scott Persons and Jeanine M. Davis (2005) Growing & Marketing Ginseng, Goldenseal & Other Woodland Medicinals Bright Mountain Books. ISBN 978-0-914875-42-0
- Richo Cech. (2002) Growing At-Risk Medicinal Herbs, Cultivation, Conservation and Ecology ISBN 978-0-9700312-1-1
- University of North Carolina, Dept. of Integrative Medicine. Monograph on Goldenseal" http://www.med.unc.edu/phyrehab/ncmedicinalherbs/goldenseal/Goldenseal-hp.pdf
License | http://creativecommons.org/licenses/by-sa/3.0/ |
Rights holder/Author | Wikipedia |
Source | http://en.wikipedia.org/w/index.php?title=Goldenseal&oldid=655037545 |
Canada
Origin: Native
Regularity: Regularly occurring
Currently: Present
Confidence: Confident
United States
Origin: Native
Regularity: Regularly occurring
Currently: Present
Confidence: Confident
License | http://creativecommons.org/licenses/by-nc/3.0/ |
Rights holder/Author | NatureServe |
Source | http://explorer.natureserve.org/servlet/NatureServe?searchName=Hydrastis+canadensis |